We use virally shaped nanoparticles as a scaffold for the generation of tailor-made vaccines. The nanoparticle base of the vaccines tricks the immune system into believing to be under viral attack, causing a strong immune response against the displayed antigen.
04.09.2024
Saiba Animal Health joins Boehringer Ingelheim (startupticker.ch)
13.06.2023
Boehringer Ingelheim obtains exclusive rights for Saiba Animal Health’s candidate (startupticker.ch)
No milestones
No Jobs
No videos and documents
No Awards
Website: 
		www.saiba-biotech.com/
		Headquarter:
		Pfäffikon 
	
			Foundation Date:
			April 2012
		
Technology:
Sectors: